Hypervision announced that it closed an oversubscribed $23 million (£17 million) Series A financing round.
Heal Capital led the financing for the London-based developer of real-time hyperspectral imaging for surgery. Angelini Ventures, IP Group and...
Hypervision announced that it closed an oversubscribed $23 million (£17 million) Series A financing round.
Heal Capital led the financing for the London-based developer of...
Axoft, a neurotechnology company, announced it has raised an oversubscribed $55 million Series A led by C.P. Group Innovation. Alumni Ventures, the Stanford President’s...
CareDx has agreed to acquire Naveris in a deal worth up to $260m, priming the company to inherit a blood‑based monitoring solution for viral‑mediated...
CorTec GmbH announced that the first participant in the University of Washington’s NIH-funded clinical trial of the Brain Interchange™ BCI system has successfully controlled...
LivaNova has published 12-month data supporting its proximal hypoglossal nerve stimulation (pHGNS) system for sleep apnea.
Findings come from the OSPREY study, which London-based LivaNova...
FeelTect has kicked off a clinical trial in Ireland to evaluate its wearable, pressure-sensing device for vein ulcers.
Researchers at the University of Galway will...
Boston Scientific announced new findings from the CHAMPION-AF trial supporting its Watchman FLX system.
Watchman FLX, Boston Scientific’s left atrial appendage closure (LAAC) device, reduces...
Hypervision announced that it closed an oversubscribed $23 million (£17 million) Series A financing round.
Heal Capital led the financing for the London-based developer of...
Axoft, a neurotechnology company, announced it has raised an oversubscribed $55 million Series A led by C.P. Group Innovation. Alumni Ventures, the Stanford President’s...
CareDx has agreed to acquire Naveris in a deal worth up to $260m, priming the company to inherit a blood‑based monitoring solution for viral‑mediated...